2015
Volume 15, Number 3, pp. 121–159
Glyphosate, pathways to modern diseases IV: cancer and related pathologies
Anthony Samsel1 and Stephanie Seneff2
1 Research Scientist, Deerfield, NH 03037, USA
2 Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA 02139, USAGlyphosate is the active ingredient in the pervasive herbicide, “Roundup”, and its usage, particularly in the United States, has increased dramatically in the last two decades, in step with the widespread adoption of “Roundup”-Ready core crops. The World Health Organization recently labelled glyphosate as “probably carcinogenic.” In this paper, we review the research literature, with the goal of evaluating the carcinogenic potential of glyphosate. Glyphosate has a large number of tumorigenic effects on biological systems, including direct damage to DNA in sensitive cells, disruption of glycine homeostasis, succinate dehydrogenase inhibition, chelation of manganese, modification to more carcinogenic molecules such as N-nitrosoglyphosate and glyoxylate, disruption of fructose metabolism, etc. Epidemiological evidence supports strong temporal correlations between glyphosate usage on crops and a multitude of cancers that are reaching epidemic proportions, including breast cancer, pancreatic cancer, kidney cancer, thyroid cancer, liver cancer, bladder cancer, and myeloid leukemia. Here, we support these correlations through an examination of Monsanto’s early studies on glyphosate, and explain how the biological effects of glyphosate could induce each of these cancers. We believe that the available evidence warrants a reconsideration of the risk/benefit trade-off with respect to glyphosate usage to control weeds, and we advocate much stricter regulation of glyphosate.
Keywords: adjuvants, cataracts, glyphosate, interstitial disease, kidney cancer, non-Hodgkin’s lymphoma, pancreatic cancer